Skip to content

Study · Observational study · 1990

1 result

[The effect of combined drug treatment on rheologic properties of the blood in patients with disordered circulatory encephalopathy].

Ishchenko MM, Ostrovskaia OS

Vrachebnoe delo1 Mar 1990Cited by 1 (Europe PMC)

PMID2368364 (opens in a new tab)PepBankPUB-02368364

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanObservational studyActivity measurement

    In patients with atherosclerotic circulatory encephalopathy, cerebrolysin was linked to increased blood viscosity.

    In plain wordsIn patients with circulatory encephalopathy, cerebrolysin was linked to increased blood viscosity.

    Outcome
    IncreaseBlood viscosity
    Study

    n: not reported in source

    Outcome group
    Vascular function · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Cerebrolysin produced a marked effect on erythrocytes, elevation of blood viscosity.
    1 context sentence
    Summary · context
    The effect of vasoactive agents, nootropic drugs and cerebrolysin on blood viscosity was studied in 128 patients with atherosclerotic disordered circulatory encephalopathy.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.